Shandong Boyuan Pharmaceutical & Chemical Co. Ltd. (301617.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

34.5x

Market Cap

CNY 8.36B

MomentumView details →

1D Return

−2.81%

YTD Return

−36.49%

RSI (14)

48.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

34.5x

Market Cap

CNY 8.36B

RSI (14)

48.6

MomentumView details →

1D Return

−2.81%

YTD Return

−36.49%

ProfitabilityView details →

Gross Margin

19.26%

Net Margin

11.35%

EBITDA Margin

15.24%

ROE (TTM)

9.79%

ROA (TTM)

8.84%

Asset Turnover

0.79x

GrowthView details →

Revenue YoY

+14.57%

EPS YoY

−44.21%

FCF YoY

—

Revenue CAGR 3Y

+22.41%

EPS CAGR 3Y

−17.41%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

7.07x

Quick Ratio

5.31x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

1.54B

Net Income (TTM)

174.25M

Op. CF (TTM)

36.11M

Latest newsMore news →

Boyuan New Materials announced adjustments to the construction content of two fundraising investment projects, optimizing capacity layout without changing the use of funds, implementation entities, locations, or total investment.18d ago

Similar companies

上大股份301522.SZ 仙琚制药002332.SZ 湘潭电化002125.SZ 北摩高科002985.SZ 宏源药业301246.SZ 华菱线缆001208.SZ

Latest newsMore news →

Boyuan New Materials announced adjustments to the construction content of two fundraising investment projects, optimizing capacity layout without changing the use of funds, implementation entities, locations, or total investment.18d ago